Pancreatic Cancer Trial, Recruiting (NCT06842303)

Pancreatic Cancer Trial, Recruiting NCT06842303 Sponsor: Central Hospital, Nancy, France Condition: Pancreatic Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06842303 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Pancreatic Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

A CT scan has shown a diagnosis of pancreatic cancer that has not spread to other parts of the body, confirmed using a specific type of detailed CT scan of the chest, abdomen, and pelvis
The person is 18 years of age or older
The person is enrolled in, or covered by, the French social security system
The person has been fully informed about how the research is organised and has signed a consent form agreeing to take part

Who may not be able to join:

People who have a medical reason why they cannot have an MRI scan
Women who are pregnant, in labour, or currently breastfeeding
People under the age of 18 who are not legally emancipated
Adults who are under a form of legal protection, such as guardianship or a court-appointed arrangement to assist with decision-making
Adults who are not able to give their own informed consent
People who are currently deprived of their liberty by a court or administrative decision
People who are receiving certain types of court-ordered psychiatric care under specific French public health laws

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 19 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0385157666

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06842303

Sponsor: Central Hospital, Nancy, France

Phase: Not Applicable

Status: Recruiting

Condition: Pancreatic Cancer

Trial contact: 0385157666

More information: https://clinicaltrials.gov/study/NCT06842303

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

A CT scan has shown a diagnosis of pancreatic cancer that has not spread to other parts of the body, confirmed using a specific type of detailed CT scan of the chest, abdomen, and pelvis
The person is 18 years of age or older
The person is enrolled in, or covered by, the French social security system
The person has been fully informed about how the research is organised and has signed a consent form agreeing to take part

Who may not be able to join:

People who have a medical reason why they cannot have an MRI scan
Women who are pregnant, in labour, or currently breastfeeding
People under the age of 18 who are not legally emancipated
Adults who are under a form of legal protection, such as guardianship or a court-appointed arrangement to assist with decision-making
Adults who are not able to give their own informed consent
People who are currently deprived of their liberty by a court or administrative decision
People who are receiving certain types of court-ordered psychiatric care under specific French public health laws

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 19 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Central Hospital, Nancy, France

Registry

ClinicalTrials.gov

Start date

6 June 2025

Est. completion

6 June 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Absolute elasticity value of the tumor (kPa) before treatment.; Absolute elasticity value of the tumor (kPa) after chemotherapy.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov